Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News

Gearing up: HBA Leadership Conference
And for the rest of us? Well, at least there’s the Healthcare Businesswoman’s Association (HBA) and its annual Leadership Conference. The event is being held next week in Chicago (and if it’s the hometown of the President, we expect it to be all the more exciting). With more than 600 attendees already registered, it will be the largest meeting of its kind. One-third of these women are vice presidents and above, so for the ladder climbers in the industry, this is the place to be.
Pharm Exec will be doing on-site blogging—so stay tuned for regular updates. In particular, we’re looking forward to the panel of “Hard Lessons, Sweet Successes,†moderated by Charlotte Sibley, HBA’s 2008 Woman of the Year. Charlotte shocked the luncheon crowd in May when she revealed her own story of the ups and downs of working in the pharmaceutical industry. (To read her story, click here) This time, she puts tough questions to an esteemed panel including Dierdre Connelly, President, Lilly USA; Len Kanavy, Vice President, Commercial Operations of Genentech; Renee Tannenbaum, Global Head, Commercial Operations, Novartis AG; Eisai’s President Lonnel Coats; and Ginger Graham, Two Trees Consulting, former CEO Amylin.